Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rhone-Poulenc Rorer

This article was originally published in The Tan Sheet

Executive Summary

Traditional year-end trade incentives to retailers and wholesalers will be discontinued this year, the company announced Oct. 21. RPR will no longer offer "extended payment terms and the opportunity to buy ahead of year-end price increases" because "in view of the trade's inventory reduction efforts, smaller price increases and forthcoming health care reform, we have determined that these practices are no longer in shareholders' best interests,' the company said. RPR estimates discontinuation of the incentives "could have a one-time impact of 1% to 2% of full-year 1993 annual sales".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082066

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel